Increasing the size of the specific pathogen free Indian rhesus macaques colony at the Southwest National Primate Research Center for AIDS, COVID-19 and other infectious diseases research
扩大西南国家灵长类动物研究中心的无特定病原体印度恒河猴群体规模,以进行艾滋病、COVID-19 和其他传染病研究
基本信息
- 批准号:10313857
- 负责人:
- 金额:$ 89.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-06-06 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAIDS/HIV problemAcquired Immunodeficiency SyndromeAcuteAddressAnimalsAntibodiesAreaAsiaBreedingCOVID-19COVID-19 pandemicCallithrixCommunicable DiseasesDiseaseEmergency SituationFundingFutureGoalsHealthHumanInfectious Diseases ResearchInfluenzaInterventionLyme DiseaseMacacaMacaca mulattaMetabolic DiseasesModelingNeurosciencesPapioPertussisPopulationPreventionPrimatesProductionReadinessResearchResearch PersonnelRhesusSARS-CoV-2 infectionTimeTuberculosisUnited States National Institutes of HealthZika Virusbuilding renovationgerm free conditioninfectious disease modelinfectious disease treatmentmodel developmentnonhuman primatepandemic diseasepathogenresponsevaccine developmentvirtual
项目摘要
Abstract.
Specific pathogen free (SPF) Indian origin Macaca mulatta (rhesus macaques) are the premier model for
infectious disease research including HIV/AIDS, TB, influenza, Lyme disease, and now COVID-19. There has
been an acute nationwide shortage of these animals over the past couple of decades, which has been well-
documented. Multiple reasons related to the COVID-19 pandemic have made this situation more difficult. Imports
of these animals from Asia have stopped, and biomedical corporates have used large number of these animals
in the past year. A number of animals have also been used in COVID-19 research by investigators at virtually
each of the seven National Primate Research Centers (NPRCs). Hence, there is an acute, urgent need to
increase the availability of SPF Indian origin rhesus macaques. This application proposes to increase the
production of these animals at the Southwest National Primate Research Center (SNPRC).
抽象的。
无特定病原体(SPF)的印度起源猕猴(恒河猴)是
传染病研究,包括艾滋病毒/艾滋病、结核病、流感、莱姆病和现在的COVID-19。一直
在过去的几十年里,这些动物在全国范围内严重短缺,这是很好的-
记录在案。与COVID-19疫情相关的多个原因令情况更加困难。进口
来自亚洲的这些动物已经停止,生物医学公司已经使用大量这些动物
过去一年许多动物也被研究人员用于COVID-19研究,
七个国家灵长类动物研究中心(NPRCs)。因此,迫切需要
增加SPF印度恒河猴的可用性。本申请建议增加
这些动物的生产在西南国家灵长类动物研究中心(SNPRC)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Larry S. Schlesinger其他文献
Mycobacterium tuberculosis remodels host transcriptome
结核分枝杆菌重塑宿主转录组
- DOI:
10.1038/s41564-021-01056-x - 发表时间:
2022-01-31 - 期刊:
- 影响因子:19.400
- 作者:
Melanie A. Carless;Larry S. Schlesinger - 通讯作者:
Larry S. Schlesinger
Identifying Mycobacterium tuberculosis virulence determinants - new technologies for a difficult problem.
识别结核分枝杆菌毒力决定因素——解决难题的新技术。
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:15.9
- 作者:
Lucy E. Desjardin;Larry S. Schlesinger - 通讯作者:
Larry S. Schlesinger
Antibody-independent classical complement pathway activation by wildtype and LPS O-antigen mutant <em>Francisella tularensis</em> strains
- DOI:
10.1016/j.molimm.2010.05.146 - 发表时间:
2010-08-01 - 期刊:
- 影响因子:
- 作者:
Corey D. Clay;John S. Gunn;Larry S. Schlesinger - 通讯作者:
Larry S. Schlesinger
Timing matters in macrophage/CD4+ T cell interactions: an agent-based model comparing emMycobacterium tuberculosis/em host-pathogen interactions between latently infected and naïve individuals
时机在巨噬细胞/CD4+T 细胞相互作用中很重要:一个基于代理的模型比较了潜伏感染和未感染个体之间的结核分枝杆菌宿主-病原体相互作用
- DOI:
10.1128/msystems.01290-24 - 发表时间:
2025-02-27 - 期刊:
- 影响因子:4.600
- 作者:
Alexis Hoerter;Alexa Petrucciani;Jordan Bonifacio;Eusondia Arnett;Larry S. Schlesinger;Elsje Pienaar - 通讯作者:
Elsje Pienaar
Impact of the elderly lung mucosa on emMycobacterium tuberculosis/em transcriptional adaptation during infection of alveolar epithelial cells
老年肺黏膜对肺泡上皮细胞感染期间结核分枝杆菌转录适应性的影响
- DOI:
10.1128/spectrum.01790-24 - 发表时间:
2024-10-30 - 期刊:
- 影响因子:3.800
- 作者:
Angélica M. Olmo-Fontánez;Anna Allué-Guardia;Andreu Garcia-Vilanova;Jeremy Glenn;Shu-Hua Wang;Robert E. Merritt;Larry S. Schlesinger;Joanne Turner;Yufeng Wang;Jordi B. Torrelles - 通讯作者:
Jordi B. Torrelles
Larry S. Schlesinger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Larry S. Schlesinger', 18)}}的其他基金
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
跨学科 NexGen 结核病研究推进中心 (IN-TRAC)
- 批准号:
10588203 - 财政年份:2022
- 资助金额:
$ 89.43万 - 项目类别:
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
跨学科 NexGen 结核病研究推进中心 (IN-TRAC)
- 批准号:
10431465 - 财政年份:2022
- 资助金额:
$ 89.43万 - 项目类别:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
健康和结核分枝杆菌感染期间的巨噬细胞核受体、代谢和免疫效应器
- 批准号:
10450960 - 财政年份:2020
- 资助金额:
$ 89.43万 - 项目类别:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
健康和结核分枝杆菌感染期间的巨噬细胞核受体、代谢和免疫效应器
- 批准号:
10457308 - 财政年份:2019
- 资助金额:
$ 89.43万 - 项目类别:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection- Diversity Supplement
健康和结核分枝杆菌感染期间的巨噬细胞核受体、代谢和免疫效应器 - Diversity Supplement
- 批准号:
10116937 - 财政年份:2019
- 资助金额:
$ 89.43万 - 项目类别:
Expansion of Marmoset Breeding Facilities to Meet Increasing Research Demands
扩建狨猴饲养设施以满足不断增长的研究需求
- 批准号:
9933536 - 财政年份:2019
- 资助金额:
$ 89.43万 - 项目类别: